Fosphenytoin
Cerebyx, Sesquient (fosphenytoin) is a small molecule pharmaceutical. Fosphenytoin was first approved as Cerebyx on 1996-08-05. It is used to treat epilepsy, seizures, and status epilepticus in the USA. Fosphenytoin sodium's patent is valid until 2033-02-27 (FDA).
| Trade Name | Cerebyx, Sesquient |
|---|---|
| Common Name | Fosphenytoin |
| Indication | epilepsy, seizures, status epilepticus |
| Drug Class | Antiepileptics (hydantoin derivatives); phosphoro-derivatives |
